BEN-OR URI enters SCINAI IMMUNOTHERAPEUTICS LTD. with 33.33M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/18/2026ACC: 0001178913-26-001172
Officer· Chief Financial Officer
Since Jan 2023
33.33M
Baseline shares
100% direct
33.33M
Direct ownership
1 position
2.52M
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Ordinary shares, no par value per share ("Ordinary Shares")
DirectShares owned33.33M
Total
33.33M direct33.33M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary shares, no par value per share ("Ordinary Shares") | 33.33M | Direct |
| Total | 33.33M | 33.33M direct |
Derivative Holdings1
American Depositary Shares
DirectUnderlying security
Ordinary Shares
Underlying shares
2.52M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
2.52M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| American Depositary Shares Direct | Ordinary Shares | — | — | 2.52M | N/A | |
| Total | 2.52M | 0.00 | ||||